Calabretta, R.; Staber, P.B.; Kornauth, C.; Lu, X.; Binder, P.; Pichler, V.; Mitterhauser, M.; Haug, A.; Li, X.; Hacker, M.
Immune Checkpoint Inhibitor Therapy Induces Inflammatory Activity in the Large Arteries of Lymphoma Patients under 50 Years of Age. Biology 2021, 10, 1206.
https://doi.org/10.3390/biology10111206
AMA Style
Calabretta R, Staber PB, Kornauth C, Lu X, Binder P, Pichler V, Mitterhauser M, Haug A, Li X, Hacker M.
Immune Checkpoint Inhibitor Therapy Induces Inflammatory Activity in the Large Arteries of Lymphoma Patients under 50 Years of Age. Biology. 2021; 10(11):1206.
https://doi.org/10.3390/biology10111206
Chicago/Turabian Style
Calabretta, Raffaella, Philipp B. Staber, Christoph Kornauth, Xia Lu, Patrick Binder, Verena Pichler, Markus Mitterhauser, Alexander Haug, Xiang Li, and Marcus Hacker.
2021. "Immune Checkpoint Inhibitor Therapy Induces Inflammatory Activity in the Large Arteries of Lymphoma Patients under 50 Years of Age" Biology 10, no. 11: 1206.
https://doi.org/10.3390/biology10111206
APA Style
Calabretta, R., Staber, P. B., Kornauth, C., Lu, X., Binder, P., Pichler, V., Mitterhauser, M., Haug, A., Li, X., & Hacker, M.
(2021). Immune Checkpoint Inhibitor Therapy Induces Inflammatory Activity in the Large Arteries of Lymphoma Patients under 50 Years of Age. Biology, 10(11), 1206.
https://doi.org/10.3390/biology10111206
